We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Hold is a Prudent Approach for CME Group (CME) Stock Now
Read MoreHide Full Article
CME Group’s (CME - Free Report) compelling product portfolio, global presence, focus on over-the-counter clearing services, effective capital deployment and favorable growth estimates make it worth retaining in one’s portfolio.
CME Group has a decent surprise history, having surpassed earnings estimates in the last six quarters.
Zacks Rank and Price Movement
CME currently carries a Zacks Rank #3 (Hold). Shares of CME Group have lost 8.8% year to date compared with the industry’s decrease of 33.6%.
Image Source: Zacks Investment Research
Optimistic Growth Projection
The Zacks Consensus Estimate for 2022 earnings is pegged at $7.91, indicating a year-over-year improvement of 18.6% on 7.3% higher revenues of $5 billion. The consensus estimate for 2023 earnings is pegged at $8.38, which indicates a year-over-year improvement of about 6% on 5% higher revenues of $5.3 billion.
The expected long-term earnings growth rate is pegged at 6.1%.
Northbound Estimate Movement
The consensus estimate for 2022 and 2023 earnings has moved 0.5% and 0.7% north, respectively, in the past 30 days, reflecting analysts’ optimism.
Business Tailwinds
CME Group’s top line should continue to benefit from a compelling portfolio. Increased volatility driving improved volumes should fuel clearing and transaction fees. Increased adoption of a greater number of crypto assets with increased interest across the entire crypto-economy should add to the upside. CME also stays focused on improving non-transactional revenues.
This largest futures exchange in the world, in terms of trading volume as well as notional value traded, boasts a solid market presence with a 90% market share of the global futures trading and clearing services. Increasing electronic trading volume adds scalability and hence leverage to CME Group’s operating model.
CME Group’s solid balance leads to adequate financial flexibility. This in turn supports investments in several growth initiatives, including organic market data growth and new product extensions and offerings, driving growth as well as effective capital deployment.
Solid Dividend History
Banking on solid cash flow, CME Group has increased dividends at a five-year CAGR (2018-2022) of 8.7%. The dividend yield is 1.6%, better than the industry average of 1.1%, making the stock an attractive pick for yield-seeking investors.
Brighthouse Financial’s earnings surpassed estimates in each of the last four quarters, the average earnings surprise being 55.91%. In the past year, BHF's stock has lost 7.4%.
The Zacks Consensus Estimate for BHF’s 2022 and 2023 earnings has moved 4.3% and 0.6% north, respectively, in the past 30 days.
The Zacks Consensus Estimate for HCI Group’s 2022 and 2023 earnings has moved 33.3% and 40% north, respectively, in the past 60 days. In the past year, HCI Group’s stock has lost 35.6%.
The Zacks Consensus Estimate for HCI’s 2022 and 2023 earnings per share indicates a year-over-year increase of 280.9% and 75%, respectively.
American Financial’s earnings surpassed estimates in each of the last four quarters, the average beat being 41.72%. In the past year, American Financial has gained 7.5%.
The Zacks Consensus Estimate for AFG’s 2022 and 2023 earnings has moved 9.8% and 6.9% north, respectively, in the past 30 days.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Why Hold is a Prudent Approach for CME Group (CME) Stock Now
CME Group’s (CME - Free Report) compelling product portfolio, global presence, focus on over-the-counter clearing services, effective capital deployment and favorable growth estimates make it worth retaining in one’s portfolio.
CME Group has a decent surprise history, having surpassed earnings estimates in the last six quarters.
Zacks Rank and Price Movement
CME currently carries a Zacks Rank #3 (Hold). Shares of CME Group have lost 8.8% year to date compared with the industry’s decrease of 33.6%.
Image Source: Zacks Investment Research
Optimistic Growth Projection
The Zacks Consensus Estimate for 2022 earnings is pegged at $7.91, indicating a year-over-year improvement of 18.6% on 7.3% higher revenues of $5 billion. The consensus estimate for 2023 earnings is pegged at $8.38, which indicates a year-over-year improvement of about 6% on 5% higher revenues of $5.3 billion.
The expected long-term earnings growth rate is pegged at 6.1%.
Northbound Estimate Movement
The consensus estimate for 2022 and 2023 earnings has moved 0.5% and 0.7% north, respectively, in the past 30 days, reflecting analysts’ optimism.
Business Tailwinds
CME Group’s top line should continue to benefit from a compelling portfolio. Increased volatility driving improved volumes should fuel clearing and transaction fees. Increased adoption of a greater number of crypto assets with increased interest across the entire crypto-economy should add to the upside. CME also stays focused on improving non-transactional revenues.
This largest futures exchange in the world, in terms of trading volume as well as notional value traded, boasts a solid market presence with a 90% market share of the global futures trading and clearing services. Increasing electronic trading volume adds scalability and hence leverage to CME Group’s operating model.
CME Group’s solid balance leads to adequate financial flexibility. This in turn supports investments in several growth initiatives, including organic market data growth and new product extensions and offerings, driving growth as well as effective capital deployment.
Solid Dividend History
Banking on solid cash flow, CME Group has increased dividends at a five-year CAGR (2018-2022) of 8.7%. The dividend yield is 1.6%, better than the industry average of 1.1%, making the stock an attractive pick for yield-seeking investors.
Stocks to Consider
Some better-ranked stocks from the finance sector are Brighthouse Financial, Inc. (BHF - Free Report) , HCI Group, Inc. (HCI - Free Report) and American Financial Group, Inc. (AFG - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Brighthouse Financial’s earnings surpassed estimates in each of the last four quarters, the average earnings surprise being 55.91%. In the past year, BHF's stock has lost 7.4%.
The Zacks Consensus Estimate for BHF’s 2022 and 2023 earnings has moved 4.3% and 0.6% north, respectively, in the past 30 days.
The Zacks Consensus Estimate for HCI Group’s 2022 and 2023 earnings has moved 33.3% and 40% north, respectively, in the past 60 days. In the past year, HCI Group’s stock has lost 35.6%.
The Zacks Consensus Estimate for HCI’s 2022 and 2023 earnings per share indicates a year-over-year increase of 280.9% and 75%, respectively.
American Financial’s earnings surpassed estimates in each of the last four quarters, the average beat being 41.72%. In the past year, American Financial has gained 7.5%.
The Zacks Consensus Estimate for AFG’s 2022 and 2023 earnings has moved 9.8% and 6.9% north, respectively, in the past 30 days.